Literature DB >> 18362045

Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.

Ute Ukelis1, Peter-Jürgen Kramer, Klaus Olejniczak, Stefan O Mueller.   

Abstract

The development of a new medicinal product is a long and costly process in particular due to the regulatory requirements for quality, safety and efficacy. There is a common interest to increase the efficiency of drug development and to provide new, better quality medicinal products much faster to the public. One possible way to economize time and costs, as well as to consider animal protection issues, is to introduce new alternative methods into non-clinical toxicity testing. Currently, animal tests are mandatory for the evaluation of acute toxicity of chemicals and new drugs. The replacement of the in vivo tests by alternative in vitro assays would offer the opportunity to screen and assess numerous compounds at the same time, to predict acute oral toxicity and thus accelerate drug development. Moreover, the substitution of in vivo tests by in vitro methods shows a proactive pursuit of ethical and animal welfare issues. Importantly, the implementation of in vitro assays for acute oral toxicity would require the establishment of common test guidelines across the EU, USA and Japan, i.e., the regions of ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use). Presently, alternative in vitro tests are being investigated internationally. Yet, in order to achieve regulatory acceptance and implementation of in vitro assays, convincing results from validation studies are required. In this review, we discuss the current regulatory status of acute oral toxicity testing and point out achievements of alternative methods. We describe the application of in vitro tests, correlating in vitro with in vivo data. The use of in vitro data to predict in vivo acute oral toxicity is analyzed using the Registry of Cytotoxicity, an official independent database. We have then analyzed opportunities and drawbacks for future implementation of in vitro test methods, with particular focus on industrial use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362045     DOI: 10.1016/j.yrtph.2008.02.002

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  9 in total

1.  Modelling compound cytotoxicity using conformal prediction and PubChem HTS data.

Authors:  Fredrik Svensson; Ulf Norinder; Andreas Bender
Journal:  Toxicol Res (Camb)       Date:  2016-10-31       Impact factor: 3.524

2.  Evaluation of Different Polymerisation Methods of Ocular Prosthesis Acrylic Resins on Subcutaneous Tissue Inflammatory Response in Rats.

Authors:  Emily V F da Silva; Marcelo C Goiato; Sandro B Bitencourt; Victor G B Brito; Aline S Takamyia; Paulo A Penitente; Sandra H P de Oliveira; Daniela M Dos Santos
Journal:  Sultan Qaboos Univ Med J       Date:  2022-05-26

3.  Acute oral toxicity of Pereskia bleo and Pereskia grandifolia in mice.

Authors:  K S Sim; A M Sri Nurestri; S K Sinniah; K H Kim; A W Norhanom
Journal:  Pharmacogn Mag       Date:  2010-02-13       Impact factor: 1.085

4.  Predicting cytotoxicity from heterogeneous data sources with Bayesian learning.

Authors:  Sarah R Langdon; Joanna Mulgrew; Gaia V Paolini; Willem P van Hoorn
Journal:  J Cheminform       Date:  2010-12-09       Impact factor: 5.514

5.  Comparative study of herbal plants on the phenolic and flavonoid content, antioxidant activities and toxicity on cells and zebrafish embryo.

Authors:  Hassan Fahmi Ismail; Zanariah Hashim; Wong Tet Soon; Nur Syukriah Ab Rahman; Ain Nabihah Zainudin; Fadzilah Adibah Abdul Majid
Journal:  J Tradit Complement Med       Date:  2017-01-16

6.  Nonanimal Models for Acute Toxicity Evaluations: Applying Data-Driven Profiling and Read-Across.

Authors:  Daniel P Russo; Judy Strickland; Agnes L Karmaus; Wenyi Wang; Sunil Shende; Thomas Hartung; Lauren M Aleksunes; Hao Zhu
Journal:  Environ Health Perspect       Date:  2019-04       Impact factor: 9.031

7.  Investigation of chitosan-g-PEG grafted nanoparticles as a half-life enhancer carrier for tissue plasminogen activator delivery.

Authors:  Arezoo Khosravi; Hadi Baharifar; Mohamad Hasan Darvishi; Ali Akbar Karimi Zarchi
Journal:  IET Nanobiotechnol       Date:  2020-12       Impact factor: 1.847

8.  Efficacy and Safety of the Immunization with DNA for Alzheimer's Disease in Animal Models: A Systematic Review from Literature.

Authors:  Yandara Akamine Martins; Cristiane Jumko Tsuchida; Patrícia Antoniassi; Izabel Galhardo Demarchi
Journal:  J Alzheimers Dis Rep       Date:  2017-12-02

Review 9.  Current status of drug screening and disease modelling in human pluripotent stem cells.

Authors:  Divya Rajamohan; Elena Matsa; Spandan Kalra; James Crutchley; Asha Patel; Vinoj George; Chris Denning
Journal:  Bioessays       Date:  2012-08-08       Impact factor: 4.345

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.